Carlos Torres-Cabala

Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Carlos Torres-Cabala is a Professor at The University of Texas MD Anderson Cancer Center in the United States. His research focuses on melanoma, immunotherapy, and the molecular mechanisms of skin cancers, as reflected in his recent publications. Notable areas of his investigation include gene expression profiles in melanocytic lesions and the role of immune checkpoint inhibitors in cancer therapy.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Keith Sweeney

Assistant Professor in Breast and Molecular Genetic Pathology

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jonathan L. Curry

UNITED STATES

View details

Alessio Giubellino, MD PhD

Associate Professor

UNITED STATES

View details

Fei Yang

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Phyu Aung

Associate Professor and Director of Surgical Pathology fellowship Program

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Roberto Miranda

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Kyu Young Song

Assistant Professor

Mayo Clinic

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carlos Torres-Cabala

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides

Gene Expression Profile of Benign, Intermediate, and Malignant Spitz and Spitzoid Melanocytic Lesions

MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-γ)-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells

Editorial for Special Issue “Molecular Mechanisms and Signaling Pathways in Melanoma”

Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy

Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition

Gamma/Delta Phenotype in Primary Cutaneous T-cell Lymphomas and Lymphoid Proliferations: Challenges for Diagnosis and Classification

Immune checkpoint inhibitor therapy as an eye-preserving treatment for locally advanced conjunctival melanoma

Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?

Langerhans cell sarcoma involving skin and showing epidermotropism: A comprehensive review

Prognostic significance of acral lentiginous histologic type in T1 melanoma

TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer

Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response

Collaborators (7)

Keith Sweeney

Jonathan L. Curry

Alessio Giubellino, MD PhD

Fei Yang

Phyu Aung

Roberto Miranda

Kyu Young Song

Make your next move.